HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Uta Kiltz Selected Research

RA 25

11/2021Non-medical switching from reference to biosimilar etanercept - no evidence for nocebo effect: a retrospective analysis of real-life data.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Uta Kiltz Research Topics

Disease

16Axial Spondyloarthritis
11/2022 - 07/2013
16Ankylosing Spondylitis
08/2022 - 09/2012
9Psoriatic Arthritis
08/2022 - 03/2015
8Pain (Aches)
01/2022 - 12/2016
7Psoriasis (Pustulosis Palmaris et Plantaris)
11/2022 - 03/2015
5Inflammation (Inflammations)
01/2022 - 09/2012
4Rheumatoid Arthritis
11/2022 - 03/2015
4Necrosis
01/2022 - 01/2016
4Non-Radiographic Axial Spondyloarthritis
01/2021 - 09/2012
3Ankylosis
01/2022 - 12/2019
3Fatigue
12/2020 - 07/2016
2Uveitis
06/2022 - 01/2019
1Connective Tissue Diseases (Connective Tissue Disease)
11/2022
1Arthritis (Polyarthritis)
11/2022
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2022
1COVID-19
01/2022
1Hepatitis B
01/2021
1Infections
01/2021
1Human Influenza (Influenza)
01/2021
1Measles
01/2021
1Rheumatic Diseases (Rheumatism)
01/2021
1Latent Tuberculosis
01/2021
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2018
1Nasopharyngitis
01/2018
1Sacroiliitis
06/2017
1Basal Cell Carcinoma (Rodent Ulcer)
03/2016
1Reinfection
03/2016
1Crohn Disease (Crohn's Disease)
03/2015

Drug/Important Bio-Agent (IBA)

8secukinumabIBA
08/2022 - 03/2015
7Biological ProductsIBA
11/2022 - 10/2017
7Antirheumatic Agents (DMARD)IBA
06/2022 - 06/2017
7C-Reactive ProteinIBA
01/2021 - 09/2012
5Tumor Necrosis Factor InhibitorsIBA
01/2021 - 07/2013
4Adalimumab (Humira)FDA Link
01/2021 - 03/2015
3Etanercept (Enbrel)FDA Link
01/2022 - 03/2015
3Biosimilar PharmaceuticalsIBA
11/2021 - 03/2015
3Monoclonal AntibodiesIBA
01/2021 - 01/2020
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2022 - 01/2017
2Interleukin-17 (Interleukin 17)IBA
01/2022 - 01/2020
2ixekizumabIBA
01/2022 - 01/2021
2ametantrone (HAQ)IBA
11/2021 - 12/2020
2CytokinesIBA
01/2021 - 03/2015
2InterleukinsIBA
01/2021 - 03/2020
2GlucocorticoidsIBA
06/2017 - 01/2016
2Infliximab (Remicade)FDA Link
03/2016 - 03/2015
1Pharmaceutical PreparationsIBA
01/2022
1COVID-19 VaccinesIBA
01/2022
1GLPG0634IBA
01/2022
1RA 25IBA
11/2021
1gamma- hydroxy- gamma- ethyl- gamma- phenylbutyramide (HEPB)IBA
01/2021
1AntibodiesIBA
01/2021
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2021
1Immunoglobulin G (IgG)IBA
01/2021
1Prostaglandins AIBA
10/2017
1N-phthaloylglutamic acidIBA
10/2017
1Analgesics (Analgesic Drugs)IBA
06/2017
1Acetaminophen (Paracetamol)FDA LinkGeneric
01/2017
1Prednisolone (Predate)FDA LinkGeneric
01/2017
1golimumabFDA Link
03/2015
1Interleukin-12 (IL 12)IBA
03/2015
1Ustekinumab (CNTO 1275)FDA Link
03/2015
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2014

Therapy/Procedure

12Therapeutics
11/2022 - 07/2013
3Biological Therapy
10/2020 - 07/2013
1Activities of Daily Living (ADL)
03/2020